Trademarkia Logo

Australia

AU$
ROVIVZEL
Cancelled: Cancelled at the request of IB

Last updated on 5 Jul 2018

Owner Info

Celgene Corporation

86 Morris Avenue

Summit NJ 07901, UNITED STATES OF AMERICA

Serial Number

1811342 filed on 23 Aug 2016

Correspondent

Camille M. Miller Cozen O'Connor

1650 Market Street,,

Suite 2800,

UNITED STATES OF AMERICA

ROVIVZEL

Classification Information


Class [005]
Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, Read More

Mark Details


Serial Number

1811342

Registered On

23 Aug 2016

Renewal On

NA

Mark Type

WORD

Legal History


Show more

Status DateAction Taken
5th Jul 2018Cancellation of Entry in Register Published
29th Jun 2018Cancel IP Right
22nd Mar 2018General Correspondence (Application or Registration)
23rd Mar 2017IP Right Registration Published
20th Mar 2017Register Trade Mark
20th Mar 2017Application Status
12th Jan 2017IP Right Acceptance Published
6th Jan 2017Amend Status from Awaiting Advertisement
12th Dec 2016Clear Examination report approved
12th Dec 2016User Created Notice correspondence sent